{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:38:59Z","timestamp":1788914339081,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007886","name":"Dana-Farber Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bvth.2025.100051","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:13:26Z","timestamp":1736900006000},"page":"100051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cardiovascular risk factors in myeloproliferative neoplasms: associations with survival and thrombotic outcomes"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6421-0117","authenticated-orcid":false,"given":"Joan","family":"How","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Leiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1329-5288","authenticated-orcid":false,"given":"Robert","family":"Redd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9065-0581","authenticated-orcid":false,"given":"Anna E.","family":"Marneth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7865-2306","authenticated-orcid":false,"given":"Daniel J.","family":"DeAngelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Dieli-Conwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"El-Jawahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9910-6141","authenticated-orcid":false,"given":"Baransel","family":"Kamaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chulwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9822-806X","authenticated-orcid":false,"given":"R. Coleman","family":"Lindsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-4529","authenticated-orcid":false,"given":"Marlise","family":"Luskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Wazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8726-6212","authenticated-orcid":false,"given":"Lachelle D.","family":"Weeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0199-9333","authenticated-orcid":false,"given":"Gabriela S.","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bvth.2025.100051_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/L18-0245","article-title":"Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms","volume":"169","author":"Hultcrantz","year":"2018","journal-title":"Ann Intern Med"},{"issue":"436","key":"10.1016\/j.bvth.2025.100051_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8292","article-title":"Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms","volume":"10","author":"Wolach","year":"2018","journal-title":"Sci Transl Med"},{"issue":"20","key":"10.1016\/j.bvth.2025.100051_bib3","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1200\/JCO.2014.57.6652","article-title":"Risk and cause of death in patients diagnosed with myeloproliferative neoplasms in Sweden between 1973 and 2005: a population-based study","volume":"33","author":"Hultcrantz","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bvth.2025.100051_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jmoldx.2016.02.003","article-title":"Validation and implementation of a custom next-generation sequencing clinical assay for hematologic malignancies","volume":"18","author":"Kluk","year":"2016","journal-title":"J Mol Diagn"},{"issue":"1","key":"10.1016\/j.bvth.2025.100051_bib5","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2020.008","article-title":"Cardiovascular risk in essential thrombocythemia and polycythemia vera: thrombotic risk and survival","volume":"12","author":"Accurso","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.bvth.2025.100051_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9124821","article-title":"The essential thrombocythemia, thrombotic risk stratification, and cardiovascular risk factors","volume":"2020","author":"Mancuso","year":"2020","journal-title":"Adv Hematol"},{"key":"10.1016\/j.bvth.2025.100051_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2147\/VHRM.S429995","article-title":"Diagnosis and management of cardiovascular risk in patients with polycythemia vera","volume":"19","author":"Benevolo","year":"2023","journal-title":"Vasc Health Risk Manag"},{"issue":"5","key":"10.1016\/j.bvth.2025.100051_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.patbio.2004.02.007","article-title":"A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP)","volume":"52","author":"Finazzi","year":"2004","journal-title":"Pathol Biol"},{"issue":"6","key":"10.1016\/j.bvth.2025.100051_bib9","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1182\/blood-2006-08-042515","article-title":"Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera","volume":"109","author":"Landolfi","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bvth.2025.100051_bib10","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1182\/blood.V112.11.5224.5224","article-title":"Dynamics, and prognostic impact, of weight loss in primary myelofibrosis","volume":"112","author":"Mesa","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bvth.2025.100051_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.leu.2404048","article-title":"Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution","volume":"20","author":"Cervantes","year":"2006","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bvth.2025.100051_bib12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2009-08-238956","article-title":"Thrombosis in primary myelofibrosis: incidence and risk factors","volume":"115","author":"Barbui","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bvth.2025.100051_bib13","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics\u20142023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.bvth.2025.100051_bib14","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1182\/blood-2012-07-444067","article-title":"Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)","volume":"120","author":"Barbui","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bvth.2025.100051_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.94","article-title":"Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia","volume":"5","author":"Barbui","year":"2015","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.bvth.2025.100051_bib16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12185-020-02887-w","article-title":"Real-world, retrospective study evaluating thromboembolic events, associated risk factors, and health-care resource utilization in Japanese patients with polycythemia vera","volume":"112","author":"Komatsu","year":"2020","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/j.bvth.2025.100051_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11239-022-02751-0","article-title":"Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemia","volume":"55","author":"Furuya","year":"2023","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"10.1016\/j.bvth.2025.100051_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/ejh.12517","article-title":"Predictors of survival and cause of death in patients with essential thrombocythemia","volume":"95","author":"Lekovic","year":"2015","journal-title":"Eur J Haematol"},{"issue":"11","key":"10.1016\/j.bvth.2025.100051_bib20","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood.V110.11.2548.2548","article-title":"Hypocholesterolemia is independently associated with decreased survival in patients with primary myelofibrosis: an analysis of lipid profiles in 558 myeloproliferative patients","volume":"110","author":"Mesa","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bvth.2025.100051_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hon.2843","article-title":"Impact of comorbidities and body mass index on the outcome of polycythemia vera patients","volume":"39","author":"Benevolo","year":"2021","journal-title":"Hematol Oncol"},{"issue":"1","key":"10.1016\/j.bvth.2025.100051_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000327","article-title":"Modifiable lifestyle and medical risk factors associated with myeloproliferative neoplasms","volume":"4","author":"Duncombe","year":"2020","journal-title":"HemaSphere"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327225000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327225000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:04:00Z","timestamp":1756307040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327225000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2950327225000087"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2025.100051","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular risk factors in myeloproliferative neoplasms: associations with survival and thrombotic outcomes","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2025.100051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100051"}}